Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database

Progressive multifocal leukoencephalopathy (PML) has been reported as the development of drugs with immunomodulatory properties, such as anticancer, immunosuppressive, and biological agents, has accelerated. To clarify an incidence profile of drug-associated PML in real-world clinical practice, we analyzed reported patients with PML using the Japanese Adverse Drug Event Report (JADER) database.

Source: Journal of the Neurological Sciences - November 14, 2023 Category: Neurology Authors: Shuji Sakurai, Mika Maezawa, Satoshi Nakao, Sakiko Hirofuji, Koumi Miyasaka, Moe Yamashita, Kensuke Matsui, Shohei Nishida, Ryo Kobayashi, Kazuhiro Iguchi, Yuichi Hayashi, Akio Suzuki, Mitsuhiro Nakamura Source Type: research